Last updated: May 29, 2026
DOCEFREZ suppliers: who manufactures, supplies, and distributes the drug and active ingredient?
DOCEFREZ is listed as an FDA-regulated pharmaceutical product. No complete supplier map can be produced from the provided inputs because “DOCEFREZ” does not uniquely identify an active ingredient, dosage form, strength, NDA/ANDA/BLA number, or FDA label/manufacturer identifiers in a way that supports a complete, accurate supplier list.
What companies supply DOCEFREZ to wholesalers and pharmacies?
Answer (required data element missing): A supplier list requires the product’s FDA identifier (NDA/ANDA/BLA) and Orange Book/label “Manufactured for” or “Distributed by” parties tied to the exact strength and dosage form. Without that mapping, a supplier enumeration would not be complete or verifiable.
Which labels and label-claim entities identify DOCEFREZ suppliers?
- “Manufactured for” (MAH or packager role)
- “Distributed by” (distribution role)
- “Manufactured by” (site and contract manufacturer role)
What is the Orange Book status of DOCEFREZ?
Answer (required data element missing): Orange Book status requires the NDA number. DOCEFREZ cannot be mapped to an Orange Book record without that identifier.
Which dossiers must be checked for DOCEFREZ?
- Original NDA record
- Listing for patents tied to dosage form and strength
- Exclusivity type (if any) and related FDA reference listed drug (RLD)
Who supplies the active pharmaceutical ingredient for DOCEFREZ?
Answer (required data element missing): API suppliers are typically not named publicly unless disclosed in FDA inspections, DMFs, or label/CMC disclosures. A verified list requires the ANDA NDA/DMF link and product-specific CMC section identifiers.
Which public sources normally surface API suppliers?
- DMF owner-of-record tied to the NDA/ANDA
- FDA inspection reports (EIRs) naming site operators
- Label and CMC correspondence, where publicly indexed
What dosage forms and strengths does DOCEFREZ have, and who supplies each?
Answer (required data element missing): Supplier responsibility can change by strength and dosage form. A complete supplier matrix requires the full labeled set (strengths, dosage forms) and the associated label “manufactured by” and “distributed by” parties for each.
How many manufacturing and packaging suppliers support DOCEFREZ?
Answer (required data element missing): Contract manufacturing and packaging are product- and site-specific. Counting suppliers requires site-level label or inspection data tied to the correct product identifier.
What to track in a DOCEFREZ supplier count
- Drug substance manufacturing sites (API)
- Drug product manufacturing sites (DP)
- Packaging sites (primary and secondary packaging)
- Role separation between MAH, packager, and manufacturer
What generic or biosimilar companies can challenge DOCEFREZ supply?
Answer (required data element missing): Competitive supply risk depends on Orange Book listings, exclusivity end dates, and whether there are Paragraph IV filings. None can be determined without the NDA/ANDA identifiers.
What to check for launch and supply disruption
- ANDA submissions to the RLD
- Patent certifications for each listed patent
- Settlement and consent decree terms (if any)
Key Takeaways
- DOCEFREZ supplier identification requires the exact FDA product record (NDA/ANDA/BLA), dosage form, strength, and FDA label/manufacturer fields.
- “DOCEFREZ” alone is not sufficient to generate a verifiable supplier list for wholesalers, pharmacies, API, drug product, or packaging.
FAQs
- How do I identify the MAH and distributor for a specific DOCEFREZ strength?
- Where can I verify the contract manufacturer listed on DOCEFREZ labeling?
- Does DOCEFREZ have a listed DMF for drug substance, and who owns it?
- What supplier changes occur when DOCEFREZ formulation or packaging is reformulated?
- How do Paragraph IV challenges affect DOCEFREZ supply continuity?
References
- FDA Orange Book: Therapeutic Equivalence Evaluations. U.S. Food and Drug Administration.
- FDA Drugs@FDA database. U.S. Food and Drug Administration.
